NCT03792659Recruiting
The EXPLORE MG Registry for Myasthenia Gravis
Exploring Outcomes and Characteristics of Myasthenia Gravis: The EXPLORE MG Registry
Source: ClinicalTrials.gov · Last updated 28 Nov 2025
Brief summary (registry, in English)
The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 800 (estimated)
- First submitted
- 2 Jan 2019
- Start date
- 30 Mar 2016
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- Yale University
- Diseases
- Myasthenia gravis
- NCT number
- NCT03792659
What you commit to
- Study type: Observational
- Planned participants: 800
- From 30 Mar 2016 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Failure to meet the Inclusion Criteria.
Who the study is looking for
- Adult patients diagnosed with Myasthenia Gravis presenting to the Yale Department of Neurology for clinical care or research interventions will be invited to donate their biological specimens/clinical data.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yale New Haven Hospital Coordinator of this site? Confirm its status | New Haven | United States | Recruiting |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.